|Day Low/High||84.00 / 84.91|
|52 Wk Low/High||76.41 / 89.72|
We continue to view Abbott as our favorite healthcare play.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CXO, GOGL, LBRDA, LBRDK Downgrades: ANIP, CTB, HVT, HVT.A, MANH, MDT, MSA, PMBC, TAYD, TGH, UBP Initiations: CJ, FTI, VREX Read on to get TheStreet Quant Ratings' detailed report:
Large-cap healthcare stocks, especially those in the medical technology sector, are one of the biggest losers in the recent market selloff.
If you are looking for the best dividend stocks out there, look no further than these top dividend aristocrats.
Healthcare executives meeting at JP Morgan Conference agree that new tax reform is good, but how it will impact the sector is not yet entirely clear.
A look at stocks seeing bullish and bearish reversal characteristics over the past week.
After two weeks of losses, the three benchmark indexes come out swinging on Tuesday. Tech and healthcare strength bolstered Wall Street gains.
After two weeks of losses, the three benchmark indexes came out swinging on Tuesday. Tech and healthcare strength bolstered Wall Street gains.
The Health Care SPDR ETF (XLV) was rising nearly 1% in afternoon trading on Tuesday, boosted in part, by solid results from medical equipment company Medtronic.
Many investors don't seem too impressed by the constantly better-than-expected earnings results from companies this quarter. But those results make it hard to be bearish, Jim Cramer says.
TheStreet's founder and Action Alerts PLUS Portfolio Manager Jim Cramer was pleased with Medtronic's latest quarterly earnings.
This pullback is a textbook example of why you can't take your cue only from the action, says Jim Cramer.
These are the 12 best investment selections from Fundstrat that may provide investors with 'timely' long-term potential.
Leerink analysts lowered their price target on Medtronic's stock and reiterated their market perform rating after the medical device maker on Oct. 6 gave an estimate of the financial impact from Hurricane Maria on its fiscal 2018 second quarter. Medtronic said it was too soon to determine the hurricane's impact, if any, beyond the quarter.
Increasing competition has made selling insulin pumps unsustainable for J&J.
The stock has been correcting to the downside since July.
Jim Cramer says commodities, China's strength, global market gains and more all point to keeping this rally alive.
America's biggest hedge funds are worth over $6 trillion combined, and here are the most common stocks they're selling.
It is tech that really is screaming to be noticed.
U.S. stock futures rise Tuesday, and shares in Europe and Asia move higher.
Jim Cramer is bullish on Novartis AG, Sirius XM Radio, Coupa Software and Juno Therapeutics.
Jim Cramer says the calendar and the momentum holders are coalescing to produce selling. Here's what investors should do about it.
Consolidation, improving equity prices and sufficient firepower for deals continue to fuel med tech M&A, according to EY's Jeff Greene.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.
A confirmation email has been sent to the address provided during registration. Please click on the appropriate link to confirm your email address.